Vivian Y. Chang, MD

In 2012, Dr. Chang joined the UCLA faculty, where she established the Cancer Predisposition Clinic with colleagues in genetics, to provide multidisciplinary clinical care of patients and families with genetic cancer susceptibility and facilitate research in this area.

Dr. Chang's research interests focus on the genetics of rare tumors, cancer predisposition, leukemogenesis, and hematopoietic stem cells after injury and aging.

Clinical interests include genetic cancer susceptibility syndromes, with a particular interest in DNA repair disorders, neurofibromatoses, overgrowth syndromes, and rare pediatric tumors. She is interested in Bloom Syndrome, Neurofibromatosis Type 1, PIK3CA related overgrowth syndrome, & Li-Fraumeni Syndrome.


Read more about cancer genetics at UCLA. 


  • PIK3CA
  • TP53
  • BLM
  • NF1